NCT01885598View on ClinicalTrials.gov

Eliquis Regulatory Post Marketing Surveillance

CompletedOBSERVATIONAL
Enrollment

3,335

Participants

Timeline

Start Date

July 10, 2013

Primary Completion Date

September 29, 2017

Study Completion Date

September 29, 2017

Conditions
NonValvular Atrial Fibrillation
Interventions
DRUG

Apixaban

Trial Locations (1)

110-756

Local Institution, Seoul

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY